Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL28854003 | 0.95 | — | — | |
| Sulfuric Acid SCHEMBL441811 | 0.95 | — | — | |
| Sulfuric Acid SCHEMBL6706133 | 0.95 | CA5A (0.67) | — | |
| Sulfuric Acid SCHEMBL28273303 | 0.90 | — | — | |
| Sulfuric Acid SCHEMBL28190551 | 0.90 | — | — | |
| Sulfuric Acid SCHEMBL27803149 | 0.90 | — | — | |
| Sulfuric Acid SCHEMBL27430135 | 0.90 | — | — | |
| Sulfuric Acid SCHEMBL27558337 | 0.90 | — | — | |
| Sulfuric Acid SCHEMBL27493822 | 0.90 | — | — | |
| Sulfuric Acid SCHEMBL28086873 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104068197-A | Multi-region chewing gum composition including isomalt gum region | CADBURY ADAMS USA LLC | 2014-10-01 | — | — | CN | disclosed |
| CN-103002885-A | Film compositions for delivery of actives | MONOSOL RX LLC | 2013-03-27 | — | — | CN | disclosed |
| CN-102670568-A | Polyethylene oxide-based films and drug delivery systems made therefrom | MONOSOLRX LLC | 2012-09-19 | — | — | CN | disclosed |
| CN-101031207-B | Liquid-filled chewing gum composition | CADBURY ADAMS USA LLC | 2012-07-04 | — | — | CN | disclosed |
| CN-1812773-B | Polyethylene oxide-based films and drug delivery systems made therefrom | MONOSOLRX LLC | 2012-06-27 | — | — | CN | disclosed |
| CN-101801177-A | sweetener compositions | CADBURY HOLDINGS LTD | 2010-08-11 | — | — | CN | disclosed |
| CN-101605463-A | Multi-Region Chewing Gum Compositions Including Isomalt Gum Regions | CADBURY ADAMS USA LLC (US) | 2009-12-16 | — | — | CN | disclosed |
| CN-100469366-C | Pharmaceutical formulation comprising a proton pump inhibitor and antacids | ASTRAZENECA AB (SE) | 2009-03-18 | — | — | CN | disclosed |
| CN-100356908-C | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom | MONOSOLRX LLC (US) | 2007-12-26 | — | — | CN | disclosed |
| CN-101031207-A | Liquid-filled chewing gum composition | CADBURY ADAMS USA LLC (US) | 2007-09-05 | — | — | CN | disclosed |
| CN-1812773-A | Polyethylene oxide-based films and drug delivery systems made therefrom | MONOSOLRX LLC (US) | 2006-08-02 | — | — | CN | disclosed |
| CN-1764443-A | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom | MONOSOLRX LLC (US) | 2006-04-26 | — | — | CN | disclosed |
| CN-1555256-A | Pharmaceutical formulation comprising a proton pump inhibitor and antacids | — | 2004-12-15 | — | — | CN | disclosed |
| CN-1131388-A | Pyrophosphate diesters for tartar control | PROCTER & GAMBLE (US) | 1996-09-18 | — | — | CN | disclosed |
| CN-1130863-A | Compositions containing phosphate ester or salt derivatives | PROCTER & GAMBLE (US) | 1996-09-11 | — | — | CN | disclosed |
| CN-1122103-A | Coated pharmaceutical composition | PROCTER & GAMBLE (US) | 1996-05-08 | — | — | CN | disclosed |